Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1981 1
1992 1
1994 1
1996 1
2001 1
2003 2
2005 2
2006 2
2007 1
2008 6
2009 5
2010 2
2011 6
2012 1
2013 1
2014 4
2015 4
2016 2
2017 1
2018 3
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for kusek pc
Search for Kussek PC instead (2 results)
Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women.
Brown JS, Nyberg LM, Kusek JW, Burgio KL, Diokno AC, Foldspang A, Fultz NH, Herzog AR, Hunskaar S, Milsom I, Nygaard I, Subak LL, Thom DH; National Institute of Diabetes and Digestive Kidney Diseases International Research Working Group on Bladder Dysfunction. Brown JS, et al. Am J Obstet Gynecol. 2003 Jun;188(6):S77-88. doi: 10.1067/mob.2003.353. Am J Obstet Gynecol. 2003. PMID: 12825024 Review.
Strategies to prevent healthcare-associated infections through hand hygiene.
Ellingson K, Haas JP, Aiello AE, Kusek L, Maragakis LL, Olmsted RN, Perencevich E, Polgreen PM, Schweizer ML, Trexler P, VanAmringe M, Yokoe DS; Society for Healthcare Epidemiology of America (SHEA). Ellingson K, et al. Infect Control Hosp Epidemiol. 2014 Aug;35(8):937-60. doi: 10.1086/677145. Infect Control Hosp Epidemiol. 2014. PMID: 25026608 No abstract available.
CKD Self-management: Phenotypes and Associations With Clinical Outcomes.
Schrauben SJ, Hsu JY, Rosas SE, Jaar BG, Zhang X, Deo R, Saab G, Chen J, Lederer S, Kanthety R, Hamm LL, Ricardo AC, Lash JP, Feldman HI, Anderson AH; CRIC Study Investigators. Schrauben SJ, et al. Am J Kidney Dis. 2018 Sep;72(3):360-370. doi: 10.1053/j.ajkd.2018.01.047. Epub 2018 Mar 24. Am J Kidney Dis. 2018. PMID: 29580660 Free PMC article.
Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
Bostom A, Pasch A, Madsen T, Roberts MB, Franceschini N, Steubl D, Garimella PS, Ix JH, Tuttle KR, Ivanova A, Shireman T, Gohh R, Merhi B, Jarolim P, Kusek JW, Pfeffer MA, Liu S, Eaton CB. Bostom A, et al. Am J Nephrol. 2018;48(1):21-31. doi: 10.1159/000491025. Epub 2018 Jul 11. Am J Nephrol. 2018. PMID: 29996127 Clinical Trial.
The glycoprotein fetuin-A is a major T50 determinant. METHODS: The Folic Acid For Vascular Outcome Prevention In Transplantation (FAVORIT) cohort is a completed, large, multiethnic controlled clinical trial cohort of chronic, stable kidney transplant recipients (KTRs). ...
The glycoprotein fetuin-A is a major T50 determinant. METHODS: The Folic Acid For Vascular Outcome Prevention In Transplantation (FAV …
Intensive blood-pressure control in hypertensive chronic kidney disease.
Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group. Appel LJ, et al. N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975. N Engl J Med. 2010. PMID: 20818902 Free PMC article. Clinical Trial.
RESULTS: During the trial phase, the mean blood pressure was 130/78 mm Hg in the intensive-control group and 141/86 mm Hg in the standard-control group. During the cohort phase, corresponding mean blood pressures were 131/78 mm Hg and 134/78 mm Hg. ...CONCLUSIONS: I …
RESULTS: During the trial phase, the mean blood pressure was 130/78 mm Hg in the intensive-control group and 141/86 mm Hg in the stan …
Use of aspirin associates with longer primary patency of hemodialysis grafts.
Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Lawson JH, Cotton JR Jr, Kusek JW, Feldman HI; Dialysis Access Consortium (DAC) Study Group. Dixon BS, et al. J Am Soc Nephrol. 2011 Apr;22(4):773-81. doi: 10.1681/ASN.2010060582. Epub 2011 Mar 17. J Am Soc Nephrol. 2011. PMID: 21415156 Free PMC article. Clinical Trial.
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. Charytan DM, et al. Kidney Int. 2019 Apr;95(4):973-982. doi: 10.1016/j.kint.2018.08.034. Epub 2018 Nov 23. Kidney Int. 2019. PMID: 30473139 Free PMC article. Clinical Trial.
42 results